Huateng Pharma, a global supplier of pharmaceutical intermediates, PEG derivatives and other chemical products, offers CAS NO.486460-00-8 for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation.
Application: BOC-(R)-3-AMINO-4-(2,4,5-TRIFLUORO-PHENYL)-BUTYRIC ACID (CAS NO.486460-00-8) has been used as a reactant for the preparation of dipeptidyl peptidase-4 (DPP4) inhibitors for the treatment of type 2 diabetes, such as sitagliptin.
Find More Sitagliptin intermediate>>
I want to comment